The review of the scientific literature examines the relevance of the use of vitamins (E, K, D, C, B vitamins) in metabolic syndrome, which is a common disease that leads to early disability and mortality of patients worldwide. The increase in morbidity leads to the search for new ways of complex treatment of both the disease itself and its complications. Currently, new nutraceuticals are under rigorous examination under strict conditions of evidence-based medicine, which is a guarantee of their effectiveness and safety. The analyzed literature contains experimental data and the results of clinical studies that confirm the effective participation of vitamins in the pathogenetic treatment of MS.